Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis.

Saved in:
Bibliographic Details
Title: Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis.
Authors: Chen, Bao Ying1,2 (AUTHOR), Salas, Jessica R.1,2 (AUTHOR), Trias, Alyssa O.1,2 (AUTHOR), Perez Rodriguez, Arely1,2 (AUTHOR), Tsang, Jonathan E.1 (AUTHOR), Guemes, Miriam3 (AUTHOR), Le, Thuc M.1,4 (AUTHOR), Galic, Zoran3 (AUTHOR), Shepard, H. Michael5 (AUTHOR), Steinman, Lawrence6 (AUTHOR), Nathanson, David A.1,4 (AUTHOR), Czernin, Johannes1,4 (AUTHOR), Witte, Owen N.1,7,8 (AUTHOR), Radu, Caius G.1,4 (AUTHOR), Schultz, Kenneth A.9 (AUTHOR), Clark, Peter M.1,2,7 (AUTHOR) pclark@mednet.ucla.edu
Source: Immunology. Jan2023, Vol. 168 Issue 1, p152-169. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00192805
DOI:10.1111/imm.13569